These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19877007)

  • 1. Antigen-specific Treg impair CD8(+) T-cell priming by blocking early T-cell expansion.
    Chappert P; Leboeuf M; Rameau P; Lalfer M; Desbois S; Liblau RS; Danos O; Davoust JM; Gross DA
    Eur J Immunol; 2010 Feb; 40(2):339-50. PubMed ID: 19877007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
    Zierden M; Kühnen E; Odenthal M; Dienes HP
    Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells.
    Zheng J; Liu Y; Qin G; Chan PL; Mao H; Lam KT; Lewis DB; Lau YL; Tu W
    J Immunol; 2009 Sep; 183(6):3742-50. PubMed ID: 19684082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
    Vocanson M; Rozieres A; Hennino A; Poyet G; Gaillard V; Renaudineau S; Achachi A; Benetiere J; Kaiserlian D; Dubois B; Nicolas JF
    J Allergy Clin Immunol; 2010 Aug; 126(2):280-9, 289.e1-7. PubMed ID: 20624644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors.
    Marzo AL; Lake RA; Robinson BW; Scott B
    Cancer Res; 1999 Mar; 59(5):1071-9. PubMed ID: 10070965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens.
    Morgan DJ; Kreuwel HT; Sherman LA
    J Immunol; 1999 Jul; 163(2):723-7. PubMed ID: 10395663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
    Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
    J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
    Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
    Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
    Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J
    Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-avidity CD8lo T cells induced by incomplete antigen stimulation in vivo regulate naive higher avidity CD8hi T cell responses to the same antigen.
    Maile R; Pop SM; Tisch R; Collins EJ; Cairns BA; Frelinger JA
    Eur J Immunol; 2006 Feb; 36(2):397-410. PubMed ID: 16402405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune-mediated intestinal inflammation-impact and regulation of antigen-specific CD8+ T cells.
    Westendorf AM; Fleissner D; Deppenmeier S; Gruber AD; Bruder D; Hansen W; Liblau R; Buer J
    Gastroenterology; 2006 Aug; 131(2):510-24. PubMed ID: 16890605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells.
    Westendorf AM; Fleissner D; Groebe L; Jung S; Gruber AD; Hansen W; Buer J
    Gut; 2009 Feb; 58(2):211-9. PubMed ID: 18832523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: priming of CD8 T cell immunity to herpes simplex virus type 1 requires cognate TLR3 expression in vivo.
    Davey GM; Wojtasiak M; Proietto AI; Carbone FR; Heath WR; Bedoui S
    J Immunol; 2010 Mar; 184(5):2243-6. PubMed ID: 20124105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo.
    Fraser JM; Janicki CN; Raveney BJ; Morgan DJ
    Immunology; 2006 Sep; 119(1):126-33. PubMed ID: 16796693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gap junctions between regulatory T cells and dendritic cells prevent sensitization of CD8(+) T cells.
    Ring S; Karakhanova S; Johnson T; Enk AH; Mahnke K
    J Allergy Clin Immunol; 2010 Jan; 125(1):237-46.e1-7. PubMed ID: 20109751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
    Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
    Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
    Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF
    Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.